Development advancing to verification and testing phase; Aims to future-proof design, lower componentry costs and improve manufacturing
NanoVibronix, Inc.(NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield, PainShield and WoundShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced a third-party contractor engaged by the Company has completed the design phase for the development of the Company's next generation PainShield and UroShield devices.
During the design phase, which was completed in December 2024, the third-party contractor developed prototypes of the Company's next generation PainShield and UroShield devices that aim to reduce both the cost of assembly and the risk profile and minimize user burden.
